SEC Form 4 · accession 0000842023-15-000002
BIO-TECHNE Corp · TECH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Howard V Oconnell
Director
Period of report
Feb 19, 2015
Accepted (ET)
Feb 20, 2015 · 1:38 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000842023
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 19, 2015 | M | 5,000 | $56.17 | A | 75,000 | I | O'Connell Trust |
| Common StockF1 | Feb 19, 2015 | S | 5,000 | $95.7764 | D | 70,000 | I | O'Connell Trust |
| Common Stock | holding | — | — | — | 2,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) | $56.17 | Feb 19, 2015 | M | 5,000 | D | Oct 26, 2006 | Oct 25, 2016 | Common Stock | 5,000 | 0 | I |
| Stock Option (right to buy) | $91.78 | holding | — | — | — | Oct 30, 2014 | Oct 30, 2024 | Common Stock | 4,000 | 4,000 | I |
| Stock Option (right to buy) | $87.39 | holding | — | — | — | Oct 31, 2013 | Oct 30, 2023 | Common Stock | 4,000 | 4,000 | I |
| Stock Option (right to buy) | $66.90 | holding | — | — | — | Oct 25, 2012 | Oct 24, 2022 | Common Stock | 5,000 | 5,000 | I |
| Stock Option (right to buy) | $70.35 | holding | — | — | — | Oct 27, 2011 | Oct 26, 2021 | Common Stock | 5,000 | 5,000 | I |
| Stock Option | $61.46 | holding | — | — | — | Oct 28, 2010 | Oct 27, 2020 | Common Stock | 5,000 | 5,000 | I |
| Stock Option (right to buy) | $63.03 | holding | — | — | — | Oct 29, 2009 | Oct 28, 2019 | Common Stock | 5,000 | 5,000 | I |
| Stock Option (right to buy) | $65.47 | holding | — | — | — | Oct 23, 2008 | Oct 22, 2018 | Common Stock | 5,000 | 5,000 | I |
| Stock Option (right to buy) | $66.59 | holding | — | — | — | Oct 25, 2007 | Oct 24, 2017 | Common Stock | 5,000 | 5,000 | I |
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.75 to $95.91 inclusive. The reporting person undertakes to provide Bio-Techne Corp., any security holder of Bio-Techne Corp. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.